Paperpal Prime Logo

Open Life Sciences : Impact Factor & More

eISSN: 2391-5412pISSN: 2391-5412
JournalOpen Access

Key Metrics

CiteScore
1.5
Impact Factor
< 5
SJR
Q4Neuroscience (all)
SNIP
0.38
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Open Life Sciences

Open Life Sciences Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher DE GRUYTER POLAND SP Z O O
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2000
Publication Time43
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2015
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 43
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Open Life Sciences ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Open Life Sciences

The protective role of whole grains and legumes against gastric cancer
  • 23 Jan 2026
  • Open Life Sciences
UC-MSCs exhibit superior antifibrotic and anti-inflammatory effects compared to BM-MSCs in a bleomycin-induced idiopathic pulmonary fibrosis model
  • 23 Jan 2026
  • Open Life Sciences
Leaf structure, physiology and transcriptome response of ancient Populus szechuanica cuttings in southwest China under different drought stresses
  • 23 Jan 2026
  • Open Life Sciences
Real-world validation of ECOG performance status and neutrophil-to-lymphocyte ratio in second-line paclitaxel plus ramucirumab for advanced gastric cancer.
  • 23 Jan 2026
  • Open life sciences
Computational approaches for the identification of potential HDAC2 inhibitors and histamine H3 receptor antagonists from Berberis vulgaris: a dual mechanistic approach for autism spectrum disorder treatment.
  • 23 Jan 2026
  • Open life sciences
The protective role of whole grains and legumes against gastric cancer
  • 23 Jan 2026
  • Open Life Sciences
UC-MSCs exhibit superior antifibrotic and anti-inflammatory effects compared to BM-MSCs in a bleomycin-induced idiopathic pulmonary fibrosis model
  • 23 Jan 2026
  • Open Life Sciences
Leaf structure, physiology and transcriptome response of ancient Populus szechuanica cuttings in southwest China under different drought stresses
  • 23 Jan 2026
  • Open Life Sciences
Real-world validation of ECOG performance status and neutrophil-to-lymphocyte ratio in second-line paclitaxel plus ramucirumab for advanced gastric cancer.
  • 23 Jan 2026
  • Open life sciences
Computational approaches for the identification of potential HDAC2 inhibitors and histamine H3 receptor antagonists from Berberis vulgaris: a dual mechanistic approach for autism spectrum disorder treatment.
  • 23 Jan 2026
  • Open life sciences

FAQs on Open Life Sciences